Regulation of lipopolysaccharide-induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-γ, tumor necrosis factor-α and interleukin-10

European Cytokine Network

Volumn 11, Issue 1, 2000, Pages 39-46

  Ter Steege, Jessica C A ^a   Van De Ven, Monique W C M ^b   Forget, P Philippe ^a   Buurman, Wim A ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

IL 10; iNOS; LPS; Mouse organs; TFN ; TNF

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; SERUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME INDUCTION; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERFERON TYPE II; INTERLEUKIN-10; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPOPOLYSACCHARIDES; LUNG; MICE; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0002818188     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 1. Bone R C. 1991. The pathogenesis of sepsis. (Review) Ann. Int. Med. 115: 457.
2. 2. Parrillo J E. 1993. Pathogenic mechanisms of septic shock. (Review) N. Eng. J. Med. 328: 1471.
3. 3. ter Steege J C A, van de Ven M W, Forget P P, Brouckaert P, Buurman W A. 1998. The role of endogenous IFN-γ, TNF-α and IL-10 in LPS-induced nitric oxide release in a mouse model. Cytokine 10: 115.
4. 4. Cook H T, Bune A J, Jansen A S, Taylor G M, Loi R K, Cattell V. 1998. Cellular localization of nitric oxide synthase in experimental endotoxin shock in the rat. Clin. Sci. 87: 179.
5. 5. Salkowski C A, Detore G, McNally R, van Rooijen N, Vogel S N. 1997. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. The roles of macrophages, endogenous IFN-γ, and TNF receptor-1-mediated signaling. J. Immunol. 158: 905.
6. 6. Buttery L D, Evans T J, Springall D R, Carpenter A, Cohen J, Polak J M. 1994. Immunohistochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab. Invest. 71: 755.
7. 7. Vallance P, Moncada S. 1993. Role of endogenous nitric oxide in septic shock. (Review) New Horizons 1: 77.
8. 8. Petros A, Bennett D, Vallance P. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 333: 1557.
9. 9. Gardiner S M, Kemp P A, March J E, Bennett T. 1995. Cardiac and regional haemodynamics, indicible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol. 116: 2005.
10. 10. Gray G A, Schott C S, Julou-Schaeffer G, Fleming I, Parrat J R, Stoclet J C. 1991. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br. J. Pharmacol. 103: 1218.
11. 11. Tepperman B L, Brown J F, Whittle B J. 1993. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am. J. Pysiol. 265: G214.
12. 12. Mercer D W, Smith G S, Cross J M, Russell D H, Chang L, Cacioppo J. 1996. Effects of lipopolysaccharide on intestinal injury: potential role of nitric oxide and lipid peroxidation. J. Surg. Res. 63: 185.
13. 13. Wilmore D W, Smith R J, O'Dwyer S T, Jacobs D O, Ziegler T R, Wang X D. 1988. The gut: a central organ after surgical stress. (Review) Surgery 104: 917.
14. 14. Chen K, Inoue M, Okada A. 1996. Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem. Bioph. Res. Commun. 224: 703.
15. 15. Nussler A K, Billiar T R. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. (Review) J. Leukoc. Biol. 54: 171.
16. 16. Brigham K L, Meyrick B. 1986. Endotoxin and lung injury. (Review) Am. Rev. Respir. Dis. 133: 913.
17. 17. Sato K, Miyakawa K, Takeya M, Hattori R, Yui Y, Sunamoto M, Ichimori Y, Ushio Y, Takahashi K. 1995. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J. Leukoc. Biol. 57: 36.
18. 18. Cunha F Q, Assreuy J, Moss D W, Rees D, Leal L M, Moncada S, Carrier M, O'Donell C A, Liew F Y. 1994. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-α and IL-1-β. Immunol 81: 211.
19. 19. Beutler B, Milsark I W, Cerami A C. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869.
20. 20. Mathison J C, Wolfson E, Ulevitch R J. 1988. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81: 1925.
21. 21. Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. 1990. Interferon γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171: 1853.
22. 22. Heinzel F P. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145: 2920.
23. 23. Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547.
24. 24. Standiford T J, Strieter R M, Lukacs N W, Kunkel S L. 1995. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necosis factor. J. Immunol. 155: 2222.
25. 25. Asai K, Kato H, Kimura S, Mukai S, Kawahito Y, Sano H, Kondo M, Akaogi K, Hirose K. 1996. Induction of gene expression for nitric oxide synthase by immunomodulating drugs in the RAW264.7 murine macrophage cell line. Cancer Immunol. Immun. 42: 275.
26. 26. Modolell M, Corraliza I M, Link F, Soler G, Eichmann K. 1995. Reciprocal regulation of nitric oxidase synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines. Eut: J. Immunol. 25: 1101.
27. 27. Martin E, Nathan C, Xie Q. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180: 977.
28. 28. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152: 3514.
29. 29. Knowles R G, Merrett M, Salter M, Moncada S. 1990. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270: 833.
30. 30. Austyn J M, Gordon S. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol 11: 805.
31. 31. Bosse R, Vestweber D. 1984. Only simultaneous blocking of the L-and P-selectin completely inhibits neutrophil migration into mouse peritoneum. Eur: J. Immunol, 24: 3019.
32. 32. Engster H P, Müller M, Karrer U, Car B D, Schnyder B, Eng V M, Woerly G, Le Hir M, Di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8: 23.
33. 33. Espevik T, Nissen-Meyer J. 1986. A highly sensitive cell line, WEH1 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99.
34. 34. Hansen M B, Nielsen S E, Berg K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 203.
35. 35. ter Steege J C, Forget P P, Buurman W A. 1999. Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model. Shock 11: 115.
36. 36. Jacobs F, Chaussabel D, Truyens C, Leclerq V, Carlier Y, Goldman M, Vray B. 1998. IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection. Clin. Exp. Immunol. 113: 59.
37. 37. Corradin S B, Fasel N, Buchmüller-Rouiller Y, Ransijn A, Smith J, Mauël J. 1993. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur: J. Immunol. 23: 2045.